Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting.

MLA

Trapè, Giulio, et al. “Treatment in Patients with Acute Myeloid Leukemia/High-Risk Myelodysplastic Syndrome with Hypomethylating Agents: Day-Hospital Management Compared to Home Care Setting.” European Journal of Haematology, vol. 111, no. 2, Aug. 2023, pp. 311–17. EBSCOhost, https://doi.org/10.1111/ejh.14012.

APA

Trapè, G., De Angelis, G., Morucci, M., Tarnani, M., De Gregoris, C., Di Veroli, A., Panichi, V., Topini, G., Bassi, L., Isidori, R., Poscente, M., Innocenti, V., Cippitelli, E. E., Talucci, R., Bertelli, S., Crocicchia, A., Lippi, A., Pezzuti, G., Fuschino, M., … Latagliata, R. (2023). Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting. European Journal of Haematology, 111(2), 311–317. https://doi.org/10.1111/ejh.14012

Chicago

Trapè, Giulio, Gioia De Angelis, Marco Morucci, Michela Tarnani, Cinzia De Gregoris, Ambra Di Veroli, Valentina Panichi, et al. 2023. “Treatment in Patients with Acute Myeloid Leukemia/High-Risk Myelodysplastic Syndrome with Hypomethylating Agents: Day-Hospital Management Compared to Home Care Setting.” European Journal of Haematology 111 (2): 311–17. doi:10.1111/ejh.14012.